Results
2533
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,533 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$921.49 | -0.2% | 67.4% | US$829.7b | US$995.42 | PE113x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$575.00 | -3.3% | 13.6% | US$531.0b | US$622.65 | PE37.6x | E23.4% | 1.5% | Healthcare | ||
JNJ | US$164.16 | -0.8% | 2.3% | US$395.2b | US$171.32 | PE24.1x | E7.2% | 3.0% | Pharmaceuticals & Biotech | ||
ABBV | US$193.47 | -0.4% | 26.7% | US$341.7b | US$196.54 | PE64.5x | E25.3% | 3.2% | Pharmaceuticals & Biotech | ||
MRK | US$117.17 | 1.1% | 10.2% | US$297.0b | US$139.03 | PE21.6x | E14.4% | 2.6% | Pharmaceuticals & Biotech | ||
AZN | UK£117.80 | -1.2% | 6.6% | UK£182.6b | UK£138.01 | PE37.8x | E16.4% | 1.9% | Pharmaceuticals & Biotech | ||
TMO | US$613.69 | 0.4% | 22.1% | US$234.4b | US$647.76 | PE37.7x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
ABT | US$113.70 | -2.3% | 15.8% | US$197.8b | US$124.12 | PE35.7x | E11.7% | 1.9% | Healthcare | ||
DHR | US$272.63 | -0.6% | 9.8% | US$196.9b | US$288.05 | PE48.5x | E14.3% | 0.4% | Pharmaceuticals & Biotech | ||
AMGN | US$337.38 | 1.5% | 26.0% | US$181.3b | US$325.55 | PE57.9x | E23.8% | 2.7% | Pharmaceuticals & Biotech | ||
ISRG | US$486.20 | -0.7% | 68.7% | US$172.8b | US$483.95 | PE82.5x | E12.5% | n/a | Healthcare | ||
PFE | US$29.42 | 0.5% | -10.0% | US$166.7b | US$33.61 | PS3x | E32.9% | 5.7% | Pharmaceuticals & Biotech | ||
SYK | US$364.81 | -1.5% | 27.9% | US$139.0b | US$372.59 | PE40.3x | E10.8% | 0.9% | Healthcare | ||
ELV | US$539.86 | -2.0% | 20.7% | US$125.2b | US$603.07 | PE18.7x | E11.6% | 1.2% | Healthcare | ||
REGN | US$1,145.03 | -0.7% | 38.8% | US$123.6b | US$1,162.19 | PE28.6x | E10.5% | n/a | Pharmaceuticals & Biotech | ||
BSX | US$83.92 | 0.7% | 56.6% | US$123.6b | US$87.26 | PE67.6x | E20.9% | n/a | Healthcare | ||
VRTX | US$464.92 | -4.2% | 33.0% | US$120.0b | US$509.82 | PS11.6x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
MDT | US$89.34 | -0.7% | 11.3% | US$114.6b | US$94.62 | PE29.2x | E11.2% | 3.1% | Healthcare | ||
GILD | US$83.94 | 1.4% | 11.9% | US$104.5b | US$83.54 | PE99.2x | E36.0% | 3.7% | Pharmaceuticals & Biotech | ||
HCA | US$404.66 | 2.5% | 60.4% | US$104.4b | US$396.60 | PE18.2x | E6.3% | 0.7% | Healthcare | ||
BMY | US$49.41 | 0.6% | -16.1% | US$100.2b | US$53.34 | PS2.2x | E49.0% | 4.9% | Pharmaceuticals & Biotech | ||
CI | US$356.14 | -2.4% | 23.0% | US$99.6b | US$398.29 | PE26.8x | E19.4% | 1.6% | Healthcare | ||
CSL | AU$293.64 | -2.2% | 16.5% | AU$142.2b | AU$309.93 | PE36.6x | E12.9% | 1.3% | Pharmaceuticals & Biotech | ||
ZTS | US$192.64 | 0.8% | 9.0% | US$87.3b | US$213.12 | PE37.2x | E10.2% | 0.9% | Pharmaceuticals & Biotech |